Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 2 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Increased sugary drink consumption tied to elevated T2D risk

Roshini Claire Anthony
23 Oct 2019
Increased sugary drink consumption tied to elevated T2D risk

An increased consumption of sugary beverages may be associated with an elevated risk of developing type 2 diabetes (T2D). Conversely, replacing sugary drinks with noncaloric drinks may reduce this risk, a large, US-based prospective study found.

Compared with individuals with a stable consumption of sugary beverages (±0.14 serving/day or ±1.0 serving/week), an increase in total sugary beverage consumption (including sugar-sweetened beverages and 100 percent fruit juice) by >0.50 serving/day (>4 ounces) over a 4-year period was associated with a 16 percent elevated risk of developing T2D over the next 4 years (hazard ratio [HR], 1.16, 95 percent confidence interval [CI], 1.01–1.34; p<0.0001). [Diabetes Care 2019;doi:10.2337/dc19-0734]

This increased risk was significant regardless of whether the increased intake pertained to sugar-sweetened beverages (HR, 1.09, 95 percent CI, 1.03–1.17; p=0.006) or 100 percent fruit juice (HR, 1.15, 95 percent CI, 1.07–1.23; p=0.004).

Similarly, a >0.50 serving/day increase in consumption of artificially-sweetened beverages over a 4-year period was associated with an 18 percent elevated risk of T2D in the following 4 years compared with a stable intake (HR, 1.18, 95 percent CI, 1.02–1.36; p=0.001).

Regardless of beverage type (sugar- or artificially-sweetened), an increase in consumption from <1 serving/week to 1 serving/day over 4 years was tied to a 15 percent increased risk of T2D in the subsequent 4 years compared with a stable consumption of <1 serving/week. Compared with <1 serving/week for 4 years, the T2D risk was 9 percent among those who decreased their consumption from 1 serving/day to <1 serving/week, while the T2D risk was 23 percent higher in those who consumed 1 serving/day for 4 years.

Any increase in consumption of artificially-sweetened beverages was associated with an elevated risk of T2D compared with <1 serving/week for 4 years. However, the researchers advised caution when interpreting these findings due to the potential for reverse causation, where individuals with a higher risk of T2D switched from sugar- to artificially-sweetened beverages for weight control, and surveillance bias, where individuals underwent more frequent diabetes screening.

“Our study suggests that increasing consumption of sugary beverages, whether they contain added or naturally occurring sugar, is associated with a higher risk of diabetes,” said the researchers.

Decreasing intake of sugar-sweetened or artificially-sweetened beverages did not appear to affect diabetes risk compared with stable intake. In contrast, replacing 1 serving/day of sugary beverages with water, coffee, tea, or reduced-fat milk was tied to a 2–10 percent reduced risk of T2D.

The results were based on analysis of participants in three cohorts namely the Nurses’ Health Study (n=76,531 women), the Nurses’ Health Study II (n=81,597 women), and the Health Professionals’ Follow-up Study (n=34,224 men) who had completed food frequency questionnaires every 4 years. A total of 11,906 confirmed cases of T2D occurred over 2,783,210 person-years of follow-up.

“The study results are in line with current recommendations to replace sugary beverages with noncaloric beverages free of artificial sweeteners. Although fruit juices contain some nutrients, their consumption should be moderated,” said study senior author Professor Frank Hu from the Harvard T. H. Chan School of Public Health in Boston, Massachusetts, US.

One mechanism postulated for the increased T2D risk was the stimulation of appetite by sugar-sweetened beverages leading to elevated calorie intake and impaired insulin sensitivity, said the researchers. With regard to artificially-sweetened beverages, previous research has suggested that artificial sweeteners may alter gut microbiota leading to glucose intolerance and may also affect insulin secretion. [Physiol Behav 2015;152:450-455]

While reflective of a real-world setting, the primarily Caucasian population may limit the generalizability of the findings, the researchers noted. Furthermore, the reasons for changing intake of sugary beverages was not accounted for.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 2 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.